Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

Gregory A Masters; Lada Krilov; Howard H Bailey; Marcia S Brose; Harold Burstein; Lisa R Diller; Don S Dizon; Howard A Fine; Gregory P Kalemkerian; Mark Moasser; Michael N Neuss; Steven J O'Day; Olatoyosi Odenike; Charles J Ryan; Richard L Schilsky; Gary K Schwartz; Alan P Venook; Sandra L Wong; Jyoti D Patel

doi:10.1200/JCO.2014.59.9746

Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology

J Clin Oncol. 2015 Mar 1;33(7):786-809. doi: 10.1200/JCO.2014.59.9746. Epub 2015 Jan 20.

Authors

Gregory A Masters¹, Lada Krilov², Howard H Bailey¹, Marcia S Brose¹, Harold Burstein¹, Lisa R Diller¹, Don S Dizon¹, Howard A Fine¹, Gregory P Kalemkerian¹, Mark Moasser¹, Michael N Neuss¹, Steven J O'Day¹, Olatoyosi Odenike¹, Charles J Ryan¹, Richard L Schilsky¹, Gary K Schwartz¹, Alan P Venook¹, Sandra L Wong¹, Jyoti D Patel¹

Affiliations

¹ Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL.
² Gregory Masters, Helen F. Graham Cancer Center, Newark, DE; Lada Krilov and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Howard H. Bailey, University of Wisconsin Hospital and Clinics, Madison, WI; Marcia S. Brose, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Harold Burstein and Lisa R. Diller, Dana-Farber Cancer Institute; Don S. Dizon, Massachusetts General Hospital, Boston, MA; Howard A. Fine, New York University Langone Medical Center; Gary K. Schwartz, Columbia University Medical Center, New York, NY; Gregory P. Kalemkerian, University of Michigan Health System; Sandra L. Wong, University of Michigan, Ann Arbor, MI; Mark Moasser, University of California San Francisco School of Medicine; Charles J. Ryan and Alan P. Venook, University of California San Francisco, San Francisco; Steven J. O'Day, Beverly Hills Health Center, Beverly Hills, CA; Michael N. Neuss, Vanderbilt-Ingram Cancer Center, Nashville, TN; Olatoyosi Odenike, University of Chicago; and Jyoti D. Patel, Northwestern University, Chicago, IL. [email protected].

PMID: 25605863
DOI: 10.1200/JCO.2014.59.9746

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Antineoplastic Agents, Hormonal / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Breast Neoplasms / prevention & control
Cancer Vaccines / therapeutic use
Drug Approval
Early Detection of Cancer / adverse effects
Early Detection of Cancer / trends
Federal Government
Female
Financing, Government
Genomics*
Humans
Immunotherapy*
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell / immunology*
Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
Male
Medical Oncology / trends*
Molecular Targeted Therapy*
Neoplasms / diagnosis
Neoplasms / drug therapy
Neoplasms / genetics
Neoplasms / metabolism
Neoplasms / prevention & control
Neoplasms / therapy*
Obesity / complications
Obesity / prevention & control
Practice Guidelines as Topic
Prostatic Neoplasms / prevention & control
Quality of Life
Rare Diseases
Research Support as Topic
Societies, Medical
United States
United States Food and Drug Administration

Substances

Antineoplastic Agents
Antineoplastic Agents, Hormonal
Cancer Vaccines